CORONA, CA, Jun 18, 2009 (MARKETWIRE via COMTEX) -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty
pharmaceutical company, announced today that Paul Bisaro, Watson's
president and chief executive officer, will provide an overview and
update of the Company's business at Wachovia's 19th Annual Mid-Year
Equity Conference on Tuesday, June 23, 2009 at 2:30 p.m. Eastern
This presentation will be webcast live and can be accessed on Watson
Pharmaceuticals' Investor Relations Web site at http://ir.watson.com.
The webcast can also be accessed at the following
An archived version will
be available for 30 days after the live presentation and can be
accessed at the same locations.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is a global leader in the development
and distribution of pharmaceuticals with a broad portfolio of generic
products and a specialized portfolio of brand pharmaceuticals focused
on Urology, Women's Health and Nephrology/Medical.
For press releases and other company information, visit Watson
Pharmaceuticals' Web site at http://www.watson.com.
Watson Pharmaceuticals, Inc.
SOURCE: Watson Pharmaceuticals